verapamil has been researched along with Coronary Vasospasm in 83 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The reasons for starting a trial of verapamil in early intervention of acute myocardial infarction (AMI) are reviewed." | 9.05 | Verapamil in acute myocardial infarction. The Danish Multicentre Study Group. ( , 1982) |
| " Based on the results of intravascular ultrasound the occlusion was suspected to be caused by coronary vasospasm, which was not relieved by intracoronary injection of isosorbide dinitrate (1 mg), but was alleviated by nicorandil (2 mg), a potassium-channel opener." | 7.74 | Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse. ( Hayashi, T; Ichikawa, M; Iwata, A; Lim, YJ; Mishima, M; Nakata, T, 2008) |
| " In carefully selected subgroup of SVG lesions without visible macrothrombus, a strategy of prophylactic intra-graft administration of abciximab and verapamil, combined with direct stenting of the graft lesion without pre-dilatation, can be safely accomplished without any significant risk of slow-flow/no-reflow phenomenon." | 6.77 | Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus. ( Bhambi, BK; Lardizabal, JA; Sandhu, R; Sharma, S; Singh, S, 2012) |
| "1." | 5.29 | Trandolapril plus verapamil inhibits the coronary vasospasm induced by hypoxia following ischemia-reperfusion injury in dogs. ( Boulanger, CM; Kirchengast, M; Lee, JJ; Vanhoutte, PM, 1996) |
| "Treatment by nitroglycerin intravenously (i." | 5.27 | Coronary vasospasm after myocardial revascularisation. Treatment by verapamil. ( Capouet, V; Deuvaert, F; Massaut, J, 1986) |
| "4 years) with coronary vasospasm were randomly treated for 3 months with benidipine, diltiazem, and verapamil, which belong to the dihydropyridine, benzothiazepine, and phenylalkylamine classes of CCBs, respectively." | 5.14 | Differential effects of calcium-channel blockers on vascular endothelial function in patients with coronary spastic angina. ( Masai, H; Miwa, Y; Shimizu, M, 2009) |
| "The reasons for starting a trial of verapamil in early intervention of acute myocardial infarction (AMI) are reviewed." | 5.05 | Verapamil in acute myocardial infarction. The Danish Multicentre Study Group. ( , 1982) |
| " Concomitant verapamil therapy for hypertension did not prevent the vasospastic effects of dihydroergotamine." | 3.77 | Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker. ( Johnson, BD; Schenkat, DH; Schulz, LT, 2011) |
| " Based on the results of intravascular ultrasound the occlusion was suspected to be caused by coronary vasospasm, which was not relieved by intracoronary injection of isosorbide dinitrate (1 mg), but was alleviated by nicorandil (2 mg), a potassium-channel opener." | 3.74 | Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse. ( Hayashi, T; Ichikawa, M; Iwata, A; Lim, YJ; Mishima, M; Nakata, T, 2008) |
| "Certain forms of coronary artery disease do not respond to treatment with Ca2+ channel blockers, and a role for endothelin-1 (ET-1) in Ca2+ antagonist-insensitive forms of coronary vasospasm has been suggested; however, the signaling mechanisms involved are unclear." | 3.72 | Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. ( Khalil, RA; McNair, LL; Salamanca, DA, 2004) |
| "In 10 cases of Prinzmetal's angina in which episodes of myocardial ischemia were easily and reproducibly induced by hyperventilation, this test was performed 111 times, 41 times under control conditions and 70 times during treatment with one or more of the following drugs: phentolamine, isosorbide dinitrate, propranolol, verapamil, nifedipine and amiodarone." | 3.66 | The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. ( Araujo, LI; Crosatto, JR; Dyszel, E; Girotti, LA; Kaski, JC; Messuti, H; Rivas, CA; Rosenbaum, MB; Vetulli, HD, 1982) |
| " In carefully selected subgroup of SVG lesions without visible macrothrombus, a strategy of prophylactic intra-graft administration of abciximab and verapamil, combined with direct stenting of the graft lesion without pre-dilatation, can be safely accomplished without any significant risk of slow-flow/no-reflow phenomenon." | 2.77 | Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus. ( Bhambi, BK; Lardizabal, JA; Sandhu, R; Sharma, S; Singh, S, 2012) |
| " Although some studies have suggested a good relation between anginal frequency and ergonovine responsiveness in these patients, none has compared ambulatory electrocardiographic activity with the results of ergonovine provocation during the long-term administration of calcium antagonists." | 2.65 | Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal's variant angina. ( Hillis, LD; Johnson, SM; Mauritson, DR; Winniford, MD, 1983) |
| "When diltiazem was compared with the placebo period during phase 1, there was a 73% decrease in frequency of angina from 1." | 2.65 | Long-term efficacy of diltiazem for control of symptoms of coronary artery spasm. ( Ginsburg, R; Lamb, IH; Rosenthal, SJ; Schroeder, JS, 1983) |
| "Twelve patients with variant angina combined with angina of effort were examined." | 2.65 | [Comparative study of the effectiveness of korinfar, izoptin and obzidan in patients with variant stenocardia combined with effort stenocardia]. ( Borisova, GA; Peres Peres, A; Shevchenko, OP; Sidorenko, BA, 1984) |
| "When nifedipine was compared with isosorbide dinitrate in a randomized crossover, double-blind trial in patients with coronary artery spasm, both drugs were shown to be efficacious and neither was superior." | 2.37 | Large vessel coronary vasospasm: diagnosis, natural history and treatment. ( Conti, CR, 1985) |
| " However, the direct cardiotoxicity in vitro and its mechanisms of toxic action remain unclear." | 1.38 | Direct cardiac toxicity of the tentacle-only extract from the jellyfish Cyanea capillata demonstrated in isolated rat heart. ( Beilei, W; Jia, L; Liang, X; Liming, Z; Lin, Z; Qian, H; Qianqian, W; Tao, W; Xiaojuan, W; Xuting, Y, 2012) |
| "Verapamil treatment eliminated evidence of vasospasm and ameliorated histological and functional evidence of cardiomyopathic progression." | 1.32 | Secondary coronary artery vasospasm promotes cardiomyopathy progression. ( Collins, KA; Earley, JU; Hack, AA; Korcarz, CE; Lang, RM; Lapidos, KA; Lyons, MR; McNally, EM; Wheeler, MT; Zarnegar, S, 2004) |
| "Verapamil/nitroglycerin was effective for at least 2 h in vitro, but did not prevent vasoconstriction after 2 h in vivo." | 1.32 | Duration of action of antispasmodic agents: novel use of a mouse model as an in vivo pharmacological assay. ( Alp, N; Channon, KM; Mussa, S; Prior, T; Taggart, DP; Wood, K, 2004) |
| "Coronary vasospasm was diagnosed based on ST elevation and myocardial failure." | 1.29 | Failure to wean from cardiopulmonary bypass after myocardial revascularization: successful treatment with verapamil via the aortic root. ( Ho, AM; Parisi, A; Shragge, BW, 1993) |
| "1." | 1.29 | Trandolapril plus verapamil inhibits the coronary vasospasm induced by hypoxia following ischemia-reperfusion injury in dogs. ( Boulanger, CM; Kirchengast, M; Lee, JJ; Vanhoutte, PM, 1996) |
| " A cumulative dose-response curve to endothelin was obtained and the curves were shifted to the right after both verapamil and nifedipine administration." | 1.28 | Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? ( Aizawa, Y; Ebe, K; Igarashi, Y; Shibata, A; Tamura, M; Yamaguchi, T, 1989) |
| "Treatment by nitroglycerin intravenously (i." | 1.27 | Coronary vasospasm after myocardial revascularisation. Treatment by verapamil. ( Capouet, V; Deuvaert, F; Massaut, J, 1986) |
| "In subjects with known migraine, the occurrence of chest pain may represent coronary artery spasm, and should be investigated with concurrent electrocardiographs, as these two clinical entities may be related as part of a generalised vasospastic disorder." | 1.27 | A possible relationship between migraine and coronary artery spasm. ( Wayne, VS, 1986) |
| "Diltiazem does not inhibit intracellular calcium release nor cause net calcium extrusion up to concentrations of 10(-5) M." | 1.26 | Selectivity of calcium antagonistic action in vascular smooth muscle. ( Fahim, M; Mangel, A; Meisheri, K; van Breemen, C, 1982) |
| "The arrhythmia was refractory to lidocaine and procainamide and only responded dramatically to verapamil, initially intravenous and afterwards oral." | 1.26 | "Torsades de pointes" invariant angina: successful treatment with verapamil. ( Cokkinos, DV; Koroxenidis, G; Tolis, G; Vorides, EM, 1981) |
| "Nifedipine was effective in all 5 cases with coronary stenosis of more than 75." | 1.26 | Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina. ( Hayakawa, H; Kimura, E; Kishida, H; Kusama, Y; Otsu, F; Takayama, M, 1982) |
| " After a single oral dose the bioavailability was only 24%, probably because of the first-pass metabolism." | 1.26 | Verapamil kinetics in normal subjects and patients with coronary artery spasm. ( Ashley, JJ; Freedman, SB; Kelly, DT; Richmond, DR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (56.63) | 18.7374 |
| 1990's | 9 (10.84) | 18.2507 |
| 2000's | 16 (19.28) | 29.6817 |
| 2010's | 11 (13.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peeters, LEJ | 1 |
| den Uil, CA | 1 |
| Feyz, L | 1 |
| van den Bemt, PMLA | 1 |
| Daemen, J | 1 |
| Versmissen, J | 1 |
| Zohourian, H | 1 |
| Bhandari, RK | 1 |
| Atanasoski McCormack, V | 1 |
| Halna du Fretay, X | 1 |
| Mohammed Saeed, D | 1 |
| Benamer, H | 1 |
| Rey, F | 1 |
| Mock, S | 1 |
| Frei, A | 1 |
| Noble, S | 1 |
| Kulkarni, M | 1 |
| Chauhan, V | 1 |
| Shetty, S | 1 |
| Politi, L | 1 |
| Monopoli, DE | 1 |
| Sgura, FA | 1 |
| Rossi, R | 1 |
| Bursi, F | 1 |
| Modena, MG | 1 |
| Hajlaoui, N | 1 |
| Tarragano, F | 1 |
| Raisky, P | 1 |
| Beaufils, P | 1 |
| Henry, P | 1 |
| Miwa, Y | 1 |
| Masai, H | 1 |
| Shimizu, M | 1 |
| Kostis, WJ | 1 |
| Suh, WM | 1 |
| Palacios, IF | 1 |
| Schenkat, DH | 1 |
| Schulz, LT | 1 |
| Johnson, BD | 1 |
| Beilei, W | 1 |
| Lin, Z | 1 |
| Qian, H | 1 |
| Qianqian, W | 1 |
| Tao, W | 1 |
| Jia, L | 1 |
| Xiaojuan, W | 1 |
| Xuting, Y | 1 |
| Liang, X | 1 |
| Liming, Z | 1 |
| Sharma, S | 1 |
| Lardizabal, JA | 1 |
| Singh, S | 1 |
| Sandhu, R | 1 |
| Bhambi, BK | 1 |
| McNair, LL | 1 |
| Salamanca, DA | 1 |
| Khalil, RA | 1 |
| Wheeler, MT | 1 |
| Korcarz, CE | 1 |
| Collins, KA | 1 |
| Lapidos, KA | 1 |
| Hack, AA | 1 |
| Lyons, MR | 1 |
| Zarnegar, S | 1 |
| Earley, JU | 1 |
| Lang, RM | 1 |
| McNally, EM | 1 |
| Reffelmann, T | 1 |
| Kloner, RA | 1 |
| Mussa, S | 1 |
| Prior, T | 1 |
| Alp, N | 1 |
| Wood, K | 1 |
| Channon, KM | 1 |
| Taggart, DP | 1 |
| Mark, B | 1 |
| Scheidt, T | 1 |
| Zeymer, U | 1 |
| Chinushi, M | 1 |
| Tagawa, M | 1 |
| Nakamura, Y | 1 |
| Aizawa, Y | 2 |
| Varenne, O | 1 |
| Jégou, A | 1 |
| Cohen, R | 1 |
| Empana, JP | 1 |
| Salengro, E | 1 |
| Ohanessian, A | 1 |
| Gaultier, C | 1 |
| Allouch, P | 1 |
| Walspurger, S | 1 |
| Margot, O | 1 |
| El Hallack, A | 1 |
| Jouven, X | 1 |
| Weber, S | 1 |
| Spaulding, C | 1 |
| Cheng, TO | 1 |
| Pragliola, C | 1 |
| Altamura, L | 1 |
| Niccoli, G | 1 |
| Siviglia, M | 1 |
| De Paulis, S | 1 |
| Possati, GF | 1 |
| Hayashi, T | 1 |
| Ichikawa, M | 1 |
| Iwata, A | 1 |
| Nakata, T | 1 |
| Lim, YJ | 1 |
| Mishima, M | 1 |
| van Breemen, C | 1 |
| Mangel, A | 1 |
| Fahim, M | 1 |
| Meisheri, K | 1 |
| Winniford, MD | 2 |
| Johnson, SM | 2 |
| Mauritson, DR | 2 |
| Hillis, LD | 2 |
| Rosenthal, SJ | 1 |
| Lamb, IH | 1 |
| Schroeder, JS | 2 |
| Ginsburg, R | 1 |
| Shevchenko, OP | 1 |
| Peres Peres, A | 1 |
| Borisova, GA | 1 |
| Sidorenko, BA | 1 |
| Parodi, O | 2 |
| Simonetti, I | 2 |
| L'Abbate, A | 2 |
| Severi, S | 1 |
| Bertrand, ME | 1 |
| Lablanche, JM | 1 |
| Tilmant, PY | 1 |
| Thieuleux, FA | 1 |
| Waters, DD | 3 |
| Szlachcic, J | 2 |
| Lette, J | 1 |
| Théroux, P | 3 |
| Angus, JA | 1 |
| Brazenor, RM | 1 |
| Le Duc, MA | 1 |
| Bory, M | 2 |
| Marie, P | 1 |
| Calaf, R | 1 |
| Sainsous, J | 1 |
| Djiane, P | 2 |
| Serradmigni, A | 1 |
| Hugenholtz, PG | 1 |
| de Jong, JW | 1 |
| Braun, LT | 1 |
| Bott-Silverman, C | 1 |
| Heupler, FA | 1 |
| Piccolo, E | 1 |
| Cazzin, R | 1 |
| Sartori, F | 1 |
| Artusi, L | 1 |
| Pascotto, P | 1 |
| Franck, R | 1 |
| Bénichou, M | 1 |
| Egre, A | 1 |
| Serradimigni, A | 1 |
| Freedman, SB | 2 |
| Richmond, DR | 2 |
| Kelly, DT | 2 |
| Rellas, JS | 1 |
| Redish, GA | 1 |
| Willerson, JT | 1 |
| Alegría, E | 1 |
| Barba, J | 1 |
| Arcas, R | 1 |
| Martín Trenor, A | 1 |
| Llorens, R | 1 |
| Malpartida, F | 1 |
| Bouchard, A | 1 |
| Cokkinos, DV | 1 |
| Tolis, G | 1 |
| Koroxenidis, G | 1 |
| Vorides, EM | 1 |
| Miller, D | 1 |
| Girotti, LA | 1 |
| Crosatto, JR | 1 |
| Messuti, H | 1 |
| Kaski, JC | 1 |
| Dyszel, E | 1 |
| Rivas, CA | 1 |
| Araujo, LI | 1 |
| Vetulli, HD | 1 |
| Rosenbaum, MB | 1 |
| Maseri, A | 1 |
| Schneck, DW | 1 |
| Altura, BM | 1 |
| Turlapaty, PD | 1 |
| Kishida, H | 1 |
| Otsu, F | 1 |
| Kusama, Y | 1 |
| Takayama, M | 1 |
| Hayakawa, H | 1 |
| Kimura, E | 1 |
| Ashley, JJ | 1 |
| Flaim, SF | 1 |
| Zelis, R | 1 |
| Pepine, CJ | 2 |
| Conti, CR | 3 |
| Fleckenstein, A | 1 |
| Fleckenstein-Grün, G | 1 |
| Fournier, JA | 1 |
| Sánchez, A | 1 |
| Cortacero, JA | 1 |
| Ho, AM | 1 |
| Parisi, A | 1 |
| Shragge, BW | 1 |
| Cohen, BM | 1 |
| Weber, VJ | 1 |
| Blum, RR | 1 |
| Ruck, BE | 1 |
| Cohen, DE | 1 |
| Haik, BJ | 1 |
| Coletti, RH | 1 |
| Lee, JJ | 1 |
| Boulanger, CM | 1 |
| Kirchengast, M | 1 |
| Vanhoutte, PM | 1 |
| Gómez Pajuelo, C | 1 |
| Gómez Sánchez, MA | 1 |
| Delgado Jiménez, JF | 1 |
| Tascón Pérez, JC | 1 |
| Rodríguez Torras, ML | 1 |
| Sáenz de la Calzada, C | 1 |
| Caputo, M | 1 |
| Nicolini, F | 1 |
| Franciosi, G | 1 |
| Gallotti, R | 1 |
| Rashid, H | 1 |
| Marshall, RJ | 1 |
| Diver, DJ | 2 |
| Breall, JA | 1 |
| He, GW | 1 |
| Fan, KY | 1 |
| Chiu, SW | 1 |
| Chow, WH | 1 |
| Verheye, S | 1 |
| Vermeersch, P | 1 |
| Tarantini, G | 1 |
| Cardaioli, P | 1 |
| Chioin, R | 1 |
| Paul, S | 1 |
| York, D | 1 |
| Pomerantz, RM | 1 |
| Kuntz, RE | 1 |
| Safian, RD | 1 |
| Baim, DS | 1 |
| Yoshida, K | 1 |
| Fujii, Y | 1 |
| Ina, H | 1 |
| Fujioka, S | 1 |
| Maseki, T | 1 |
| Abe, T | 1 |
| Asao, Y | 1 |
| Hirai, Y | 1 |
| Wake, M | 1 |
| Yamashita, M | 1 |
| Okada, M | 1 |
| Mizuno, Y | 1 |
| Igarashi, Y | 1 |
| Tamura, M | 1 |
| Ebe, K | 1 |
| Yamaguchi, T | 1 |
| Shibata, A | 1 |
| Feldman, RL | 1 |
| Hill, JA | 1 |
| Mossier, M | 1 |
| Hasin, Y | 1 |
| Gotsman, MS | 1 |
| Leitold, M | 1 |
| Hader, S | 1 |
| Babbitt, DG | 1 |
| Perry, JM | 1 |
| Forman, MB | 1 |
| Capouet, V | 1 |
| Massaut, J | 1 |
| Deuvaert, F | 1 |
| Tapp, WN | 1 |
| Natelson, BH | 1 |
| Sosnowski, M | 1 |
| Markiewicz, A | 1 |
| Leitz, KH | 1 |
| Tsilimingas, N | 1 |
| Oster, H | 1 |
| Scherer, HE | 1 |
| Hörmann, E | 1 |
| Engel, HJ | 1 |
| Wayne, VS | 1 |
| Katsumoto, K | 1 |
| Takeuchi, K | 1 |
| Niibori, T | 1 |
| Okuno, T | 1 |
| Sonnenblick, EH | 1 |
| Fein, F | 1 |
| Capasso, JM | 1 |
| Factor, SM | 1 |
| Nussmeier, NA | 1 |
| Slogoff, S | 1 |
| Kenny, J | 1 |
8 reviews available for verapamil and Coronary Vasospasm
| Article | Year |
|---|---|
[Coronary spastic angina refractory to optimal medical therapy treated by angioplasty and stenting. A case report and review of literature].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Vasospasm; Human | 2010 |
[Treatment of coronary arterial spasm].
Topics: Amiodarone; Coronary Vasospasm; Denervation; Diltiazem; Humans; Isosorbide Dinitrate; Myocardial Rev | 1982 |
[An anomalous origin of the left coronary artery associated with a right coronary spasm as the cause of angina and presyncope].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessel Anomalies; Dru | 1999 |
Large vessel coronary vasospasm: diagnosis, natural history and treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aspirin; Coronary Artery Bypass; Coronary | 1985 |
Calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Calcium Channel Blockers; Coronary Circulatio | 1985 |
Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy.
Topics: Animals; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Coronary Vasospasm; Cricetinae; Heart Failu | 1985 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exe | 1985 |
Calcium channel blocking agents and the heart.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Vasospasm; Digoxin; Diltia | 1985 |
12 trials available for verapamil and Coronary Vasospasm
| Article | Year |
|---|---|
Differential effects of calcium-channel blockers on vascular endothelial function in patients with coronary spastic angina.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Coronary Vasospasm; Dihydropyridines; Diltiazem; End | 2009 |
Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus.
Topics: Abciximab; Administration, Intravenous; Aged; Antibodies, Monoclonal; Coronary Vasospasm; Female; Gr | 2012 |
Prevention of arterial spasm during percutaneous coronary interventions through radial artery: the SPASM study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Vasospasm; Double-Blind Method; Drug Therapy, Combina | 2006 |
Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal's variant angina.
Topics: Adult; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasosp | 1983 |
Long-term efficacy of diltiazem for control of symptoms of coronary artery spasm.
Topics: Adult; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasospasm; Diltiaz | 1983 |
[Comparative study of the effectiveness of korinfar, izoptin and obzidan in patients with variant stenocardia combined with effort stenocardia].
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic | 1984 |
Calcium inhibitors in the treatment of arterial spasm: verapamil.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasospasm; Coronary Ve | 1983 |
[Objective evaluation of calcium antagonists in Prinzmetal's angina with the ergonovine test].
Topics: Adult; Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Diltiazem; Elec | 1983 |
Verapamil in acute myocardial infarction. The Danish Multicentre Study Group.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Coronary Care Units; Coronary Vasospasm; Denmark | 1982 |
Effects of oral calcium-antagonists in spontaneous angina. Verapamil and nifedipine in a double-blind cross-over trial.
Topics: Angina Pectoris; Angina Pectoris, Variant; Clinical Trials as Topic; Coronary Vasospasm; Double-Blin | 1982 |
[Ergometrine test in the evaluation of drugs for spastic angina].
Topics: Adult; Angina Pectoris, Variant; Benzazepines; Clinical Trials as Topic; Coronary Vasospasm; Diltiaz | 1981 |
Verapamil therapy for Prinzmetal's variant angina: comparison with placebo and nifedipine.
Topics: Angina Pectoris, Variant; Blood Pressure; Coronary Vasospasm; Exercise Test; Female; Heart Rate; Hum | 1982 |
63 other studies available for verapamil and Coronary Vasospasm
| Article | Year |
|---|---|
Acute calcium channel blocker withdrawal-induced cardiac arrest.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Diagnosis, Differential; Female; Hear | 2019 |
Late perioperative native coronary artery spasm following bypass grafting in a patient with anomalous aortic origin of the coronary artery.
Topics: Cardiotonic Agents; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; C | 2019 |
[Diagnosis and treatment of spastic angina revealed by cardiac arrest].
Topics: Adult; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Defibrillators, Im | 2014 |
Vasospastic angina: A forgotten acute coronary syndrome and the usefulness of twelve-lead electrocardiogram monitoring in diagnosis.
Topics: Adult; Angina Pectoris, Variant; Angiotensin-Converting Enzyme Inhibitors; Coronary Vasospasm; Disea | 2016 |
Reversible Cerebral Vasoconstriction Syndrome.
Topics: Adult; Brain Infarction; Circle of Willis; Coronary Vasospasm; Female; Headache Disorders, Primary; | 2016 |
Images in cardiovascular medicine. Spontaneous echocardiographic wall motion abnormalities in variant angina.
Topics: Angina Pectoris, Variant; Coronary Vasospasm; Echocardiography; Electrocardiography; Humans; Isosorb | 2008 |
Acute myocardial infarction caused by multivessel coronary spasm due to calcium channel blocker withdrawal.
Topics: Calcium Channel Blockers; Coronary Angiography; Coronary Vasospasm; Drug Administration Schedule; El | 2011 |
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; | 2011 |
Direct cardiac toxicity of the tentacle-only extract from the jellyfish Cyanea capillata demonstrated in isolated rat heart.
Topics: Animals; Calcium Channels, L-Type; Cnidarian Venoms; Coronary Vasospasm; Dose-Response Relationship, | 2012 |
I am a 37-year-old woman and was diagnosed with coronary artery spasms two years ago. I am taking Plavix, verapamil and Imdur for my condition. What other things can I do to help my heart?
Topics: Adult; Clopidogrel; Coronary Vasospasm; Coronary Vessels; Female; Health Behavior; Health Knowledge, | 2011 |
Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessels; Diltiazem; Disease | 2004 |
Secondary coronary artery vasospasm promotes cardiomyopathy progression.
Topics: Animals; Calcium Channel Blockers; Cardiomyopathies; Coronary Vasospasm; Cytoskeletal Proteins; Dise | 2004 |
Effects of adenosine and verapamil on anatomic no-reflow in a rabbit model of coronary artery occlusion and reperfusion.
Topics: Adenosine; Animals; Blood Pressure; Coronary Disease; Coronary Vasospasm; Disease Models, Animal; Ma | 2004 |
Duration of action of antispasmodic agents: novel use of a mouse model as an in vivo pharmacological assay.
Topics: Animals; Aorta; Coronary Artery Bypass; Coronary Vasospasm; Drug Combinations; Male; Mice; Mice, Inb | 2004 |
Large myocardial infarction and a severe spasm of the left coronary artery.
Topics: Adult; Contrast Media; Coronary Angiography; Coronary Vasospasm; Diagnosis, Differential; Female; Fo | 2004 |
Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Bundle-Branch Block; Coronary Vasospasm; Electrocard | 2006 |
What is the SPASM study?
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Vasospasm; Drug Therapy, Combination; Female; Humans; | 2007 |
Postoperative coronary artery spasm complicating aortic valve replacement: implications for identification and treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Insufficiency; Coronary Angiography; Coronary | 2007 |
Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse.
Topics: Coronary Vasospasm; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Nicorandil; Sho | 2008 |
Selectivity of calcium antagonistic action in vascular smooth muscle.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessels; Diltiazem; Dose-Re | 1982 |
[Strategy of the treatment of vasospastic angina pectoris].
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Arteriosclerosis; Coronary Artery Bypass; Coronary Vaso | 1983 |
Responses of dog large coronary arteries to constrictor and dilator substances: implications for the cause and treatment of variant angina pectoris.
Topics: Angina Pectoris, Variant; Animals; Arteries; Constriction, Pathologic; Coronary Vasospasm; Coronary | 1983 |
[Prognostic value of coronary spasm threshold determined by the ergometrine test].
Topics: Coronary Vasospasm; Diltiazem; Ergonovine; Humans; Prognosis; Time Factors; Verapamil | 1984 |
Mechanism(s) of calcium antagonists and ischemia.
Topics: Adenosine Triphosphate; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Circul | 1984 |
Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
Topics: Calcium; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessels; Diltiazem; Humans; Muscle C | 1983 |
Natural history of pure coronary artery spasm in patients treated medically.
Topics: Adult; Aged; Coronary Artery Bypass; Coronary Vasospasm; Electrocardiography; Ergonovine; Female; Fo | 1983 |
Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm.
Topics: Coronary Angiography; Coronary Vasospasm; Electrocardiography; Ergonovine; Exercise Test; Female; Fo | 1982 |
Spontaneous remission is a frequent outcome of variant angina.
Topics: Adult; Angina Pectoris, Variant; Coronary Angiography; Coronary Vasospasm; Diltiazem; Electrocardiog | 1983 |
"Torsades de pointes" invariant angina: successful treatment with verapamil.
Topics: Administration, Oral; Adult; Angina Pectoris, Variant; Arrhythmias, Cardiac; Coronary Vasospasm; Ele | 1981 |
Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month.
Topics: Adult; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Death, Sudden; Diltiazem; Ele | 1982 |
The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina.
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Coronary Vasospasm; Diagnosis, Differential; Electrocar | 1982 |
Verapamil versus propranolol for angina at rest.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Ergonovine; Humans; | 1982 |
Therapeutic rounds at The Milton S. Hershey Medical Center.
Topics: Adult; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Humans; Male; Nifedip | 1982 |
Withdrawal of magnesium enhances coronary arterial spasms produced by vasoactive agents.
Topics: Angiotensin Amide; Angiotensin II; Animals; Coronary Vasospasm; Dogs; Female; In Vitro Techniques; M | 1982 |
Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Dilti | 1982 |
Verapamil kinetics in normal subjects and patients with coronary artery spasm.
Topics: Administration, Oral; Adult; Coronary Vasospasm; Female; Half-Life; Humans; Kinetics; Liver; Male; M | 1981 |
Clinical use of calcium entry blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Cinnarizine; Coronary Circulation; Coronary Vasospasm; Di | 1981 |
Calcium blockers in coronary heart disease. Part II.
Topics: Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Diltiazem; Humans; Nifedipin | 1981 |
Cardiovascular protection by Ca antagonists.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular System; Coronary Vasospasm; Diltia | 1980 |
Selective ergonovine-induced coronary artery spasm and ST-segment alternans after blunt thoracic trauma.
Topics: Adult; Angina Pectoris, Variant; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Ergo | 1995 |
Failure to wean from cardiopulmonary bypass after myocardial revascularization: successful treatment with verapamil via the aortic root.
Topics: Cardiopulmonary Bypass; Coronary Vasospasm; Humans; Injections, Intra-Arterial; Male; Middle Aged; M | 1993 |
Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot.
Topics: Aged; Anticoagulants; Atherectomy, Coronary; Cardiac Pacing, Artificial; Coronary Disease; Coronary | 1996 |
Trandolapril plus verapamil inhibits the coronary vasospasm induced by hypoxia following ischemia-reperfusion injury in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Coronary Vasospasm; Dog | 1996 |
Coronary artery spasm after coronary artery bypass grafting.
Topics: Cardiac Catheterization; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Coronary Va | 1999 |
Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report.
Topics: Adenosine; Adult; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Diagnosis, Differentia | 2000 |
Injection of vasodilators into arterial grafts through cardiac catheter to relieve spasm.
Topics: Aged; Cardiac Catheterization; Coronary Artery Bypass; Coronary Vasospasm; Humans; Infusions, Intrav | 2000 |
Atropine for therapy refractory acute coronary spasm.
Topics: Atropine; Coronary Vasospasm; Humans; Muscarinic Antagonists; Nitroglycerin; Treatment Failure; Vaso | 2000 |
Images in cardiovascular medicine. Coronary spasm resistant to intracoronary nitrates following successful stent implantation.
Topics: Angioplasty, Balloon; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Humans; Male; Mid | 2001 |
Cocaine abuse: an expanding healthcare problem for the 1990s.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiomyopathies; C | 1992 |
Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; H | 1991 |
[Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction].
Topics: Animals; Calcium Channel Blockers; Cardioplegic Solutions; Coronary Vasospasm; Diltiazem; Dogs; Nica | 1990 |
[A case of coronary spasm during general anesthesia successfully treated with nitroglycerin and verapamil].
Topics: Aged; Anesthesia, General; Coronary Vasospasm; Humans; Male; Nitroglycerin; Verapamil | 1989 |
Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Dogs; Dose-Resp | 1989 |
Acute beta-blocker withdrawal and exchange by verapamil before percutaneous transluminal angioplasty.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon; Coronary Vasospasm; Humans; Substance Withdrawal | 1988 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Is | 1986 |
Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon; Coronary Angiography; Coronary Vasospasm; Female; Hu | 1988 |
Coronary vasospasm after myocardial revascularisation. Treatment by verapamil.
Topics: Coronary Vasospasm; Humans; Male; Middle Aged; Myocardial Revascularization; Nitroglycerin; Postoper | 1986 |
Verapamil sensitizes cardiomyopathic hamsters to the effects of stress.
Topics: Animals; Cardiomyopathies; Coronary Vasospasm; Cricetinae; Stress, Physiological; Verapamil | 1988 |
[Withdrawal syndrome after discontinuation of calcium channel blockers].
Topics: Coronary Disease; Coronary Vasospasm; Humans; Nifedipine; Substance Withdrawal Syndrome; Verapamil | 1988 |
[Coronary spasm immediately following coronary revascularization].
Topics: Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Coronary Vessels | 1988 |
A possible relationship between migraine and coronary artery spasm.
Topics: Coronary Disease; Coronary Vasospasm; Electrocardiography; Female; Humans; Middle Aged; Migraine Dis | 1986 |
[Aorto-coronary bypass surgery in variant angina and ST-elevation angina].
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Coronary Vasospasm; | 1986 |
Verapamil treatment of intraoperative coronary artery spasm.
Topics: Coronary Artery Bypass; Coronary Vasospasm; Electrocardiography; Humans; Injections, Intravenous; In | 1985 |